FR2322373A1 - Methode et necessaire de dosage immunologique d'un antigene en phase solide - Google Patents

Methode et necessaire de dosage immunologique d'un antigene en phase solide

Info

Publication number
FR2322373A1
FR2322373A1 FR7621350A FR7621350A FR2322373A1 FR 2322373 A1 FR2322373 A1 FR 2322373A1 FR 7621350 A FR7621350 A FR 7621350A FR 7621350 A FR7621350 A FR 7621350A FR 2322373 A1 FR2322373 A1 FR 2322373A1
Authority
FR
France
Prior art keywords
antigen
necessary
solid phase
immunological determination
immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7621350A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
New England Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp filed Critical New England Nuclear Corp
Publication of FR2322373A1 publication Critical patent/FR2322373A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR7621350A 1975-08-28 1976-07-12 Methode et necessaire de dosage immunologique d'un antigene en phase solide Withdrawn FR2322373A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/608,621 US4092408A (en) 1975-08-28 1975-08-28 Method for solid phase immunological assay of antigen

Publications (1)

Publication Number Publication Date
FR2322373A1 true FR2322373A1 (fr) 1977-03-25

Family

ID=24437293

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621350A Withdrawn FR2322373A1 (fr) 1975-08-28 1976-07-12 Methode et necessaire de dosage immunologique d'un antigene en phase solide

Country Status (6)

Country Link
US (1) US4092408A (fr)
CA (1) CA1079633A (fr)
DE (1) DE2633877A1 (fr)
FR (1) FR2322373A1 (fr)
GB (1) GB1518418A (fr)
SE (1) SE7607403L (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415301A1 (fr) * 1978-01-23 1979-08-17 Baxter Travenol Lab Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon
FR2433749A1 (fr) * 1978-07-28 1980-03-14 Abbott Lab Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
EP0078734A1 (fr) * 1981-10-29 1983-05-11 BIOMERIEUX, Société Anonyme dite Procédé de dosage immunologique mettant en oeuvre deux anticorps, le deuxième anticorps étant purifié par chromatographie d'affinité, supports pour sa mise en oeuvre
EP0575998A1 (fr) * 1992-06-26 1993-12-29 Becton, Dickinson and Company Procédé en deux étapes pour revêtir une phase solide avec des anticorps
FR2917171A1 (fr) * 2007-06-07 2008-12-12 Biosynex Sarl Methode de detection d'une molecule d'interet dans un echantillon liquide.

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34394E (en) * 1978-01-23 1993-09-28 Baxter Diagnostics Inc. Method and composition for double receptor, specific binding assays
US4189464A (en) * 1978-05-05 1980-02-19 Institute For Cancer Research Hepatitis B testing reagent and method
US4305924A (en) * 1979-08-08 1981-12-15 Ventrex Laboratories, Inc. Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US5009996A (en) * 1980-06-30 1991-04-23 International Immunoassay Laboratories, Inc. Two site cross-reaction immunometric sandwich assay method
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4363634A (en) * 1980-07-18 1982-12-14 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
US4537861A (en) * 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4871683A (en) * 1985-04-18 1989-10-03 Beckman Instruments, Inc. Apparatus and method using a new reaction capsule
US5045479A (en) * 1988-07-05 1991-09-03 The Johns Hopkins University Continuous flow competitive assay with reference system
US5188937A (en) * 1989-04-06 1993-02-23 Becton, Dickinson And Company Layered sandwich assay method for chlamydia and materials therefor
US5429929A (en) * 1991-04-19 1995-07-04 The Trustees Of Columbia University In The City Of New York Method for detecting antibodies to a neuroblastoma antigen in mental illness
JPH06508217A (ja) * 1992-01-06 1994-09-14 デイド、ベーリング、インコーポレイテッド 結合蛋白質捕捉アッセイ
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
US20040259113A1 (en) * 1993-07-22 2004-12-23 Mayo Foundation For Medical Education And Research, Hybritech Incorporated Method for detection of metastatic prostate cancer
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
WO1995030758A1 (fr) * 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Polypeptide hk2 recombine
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
WO1998059073A1 (fr) 1997-06-20 1998-12-30 Mayo Foundation For Medical Education And Research Procede de detection du cancer du sein
US20050019944A1 (en) * 2003-07-23 2005-01-27 Eastman Kodak Company Colorable microspheres for DNA and protein microarray
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA
WO2009120880A2 (fr) 2008-03-26 2009-10-01 Zonit Structured Solutions, Llc Systèmes et méthodologies de distribution de puissance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US3904367A (en) * 1973-08-15 1975-09-09 Gen Electric Contrast enhancement for immunological film detection
US3876504A (en) * 1974-06-10 1975-04-08 Early Warning Co Procedure for determination of antigens and antibodies and articles for use therewith
US3979509A (en) * 1974-09-03 1976-09-07 General Electric Company Opaque layer method for detecting biological particles

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415301A1 (fr) * 1978-01-23 1979-08-17 Baxter Travenol Lab Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon
FR2433749A1 (fr) * 1978-07-28 1980-03-14 Abbott Lab Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
EP0078734A1 (fr) * 1981-10-29 1983-05-11 BIOMERIEUX, Société Anonyme dite Procédé de dosage immunologique mettant en oeuvre deux anticorps, le deuxième anticorps étant purifié par chromatographie d'affinité, supports pour sa mise en oeuvre
EP0575998A1 (fr) * 1992-06-26 1993-12-29 Becton, Dickinson and Company Procédé en deux étapes pour revêtir une phase solide avec des anticorps
FR2917171A1 (fr) * 2007-06-07 2008-12-12 Biosynex Sarl Methode de detection d'une molecule d'interet dans un echantillon liquide.

Also Published As

Publication number Publication date
CA1079633A (fr) 1980-06-17
GB1518418A (en) 1978-07-19
US4092408A (en) 1978-05-30
DE2633877A1 (de) 1977-03-10
SE7607403L (sv) 1977-02-21

Similar Documents

Publication Publication Date Title
FR2322373A1 (fr) Methode et necessaire de dosage immunologique d'un antigene en phase solide
DK149968C (da) Fremgangsmaade til immunkemisk maengdebestemmelse af et antigen
JPS5283933A (en) Serum physiological method for detecting presence of nigeria gonoroe antigen
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
IT1110354B (it) Sviluppatore per elettrofotografia e procedimento per la sua preparazione
BE863810A (fr) Procede de preparation d'un antigene et d'un anticorps
IL51636A0 (en) Method and apparatus for analysing the concentration of antigen or antibody by radioimmunoassay
BE843061A (fr) Procede et appareil de determination de l'angle de calage d'un moteur diesel
GB2015156B (en) Determination of antigens of antibodies
BE888906A (fr) Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
IT1062433B (it) Reagente immunologico e metodo di suo uso
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
FR2301825A1 (fr) Detection de l'antigene de surface de l'hepatite b par agglutination de latex
IT1104619B (it) Antigeni e anticorpi della teofillina
JPS51151323A (en) Mesurement of antibody or antigen
BE857121A (fr) Antigene et anticorps pour un essai de determination immunologique de la thymopoietine, et leur application
IL61641A0 (en) Immunological detection of human cancer cells and antigens and antibodies for use therein
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
JPS5396316A (en) Analysis of antigen * antibody or antigenn antibody complex in liquid
IT1068012B (it) Procedimento e dispositivo per la combustione di combustibili pregiati
JPS5543498A (en) Method of detecting and determining complement fixation antibody
FR2347688A1 (fr) Nouvel antigene afferent aux maladies du foie et reactif pour la detection d'anticorps alpha-l et d'antigenes alpha-l
BE858406A (fr) Nouveau procede de dosage d'antigenes et d'anticorps
JPS5294419A (en) Control of antigen and antibody * and utilization of antibody
JPS5667757A (en) Method of detecting and determining hapten and antigen

Legal Events

Date Code Title Description
ST Notification of lapse